MoonLake ImmunotherapeuticsMLTX 
$53.114.16%24h
4.16%24h
Global rank3836
Market cap$3.18B
Change 7d12.93%
YTD Performance-11.04%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Market capitalization of MoonLake Immunotherapeutics (MLTX)
As of November 2024, MoonLake Immunotherapeutics has a market cap of $3.18B. This makes MoonLake Immunotherapeutics the world's 3836th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of MoonLake Immunotherapeutics from 2020 to 2024
-
Value:-
Market cap history of MoonLake Immunotherapeutics from 2020 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $3.56B | -1.62% |
| 2023 | $3.62B | 475.14% |
| 2022 | $629.38M | 6.17% |
| 2021 | $592.81M | -13.02% |
| 2020 | $681.52M | - |
MLTX Market Cap Today is $3.18B 4.16% - 4 Nov 2024
View largest stocks by market cap 
